| |
| No 10/2021 | December Issue |
|
|
Dear Readers,
As a modern research institute, the BIH is committed to having a gender and diversity sensitive organizational structure. As a key building block towards this goal, we have decided to establish gender parity on all supervisory bodies that advise and support the Board of Directors. This also applies to elected bodies – we are thus setting an example that is being watched with considerable interest by other research institutions. We have just successfully completed the elections for the Section Management posts and the Extended Board of Directors, so that women and men can play an equal role in continuing to make the BIH a successful research institute for medical translation. We are very pleased about this. More information about the elections, and especially about who was elected, can be found in the current newsletter.
During the upcoming holiday season, we wish you and your families a few quiet moments together so that you can leave the worries and stresses of the past weeks and months behind. Have a good break and a healthy start to the New Year.
With best wishes,
Christopher Baum and Michael Frieser
|
|
Scientists from the BIH and the MDC, together with colleagues from Heidelberg and Barcelona, have traced the development of blood cells in detail: They combined methods used to analyze gene activity within the cell with those used to detect protein molecules on the cell surface. This enabled them to simultaneously capture information on thousands of individual cells from blood and bone marrow and thus clearly identify the different developmental stages of the various cell types. The scientists have now published their findings, which are important for the diagnosis and treatment of blood cancers, in the journal Nature Immunology. Read the press release
Read the publication |
|
|
The International Health-Tech Pilot Program promotes forward-looking healthcare solutions from Israel. Now, the first collaboration agreements between Israeli start-up companies, Charité, the BIH and the Israel Innovation Authority have been successfully concluded. The collaboration of the start-ups with their clinical partners will start in early 2022. The Authority is already planning a second call for proposals to support international collaboration projects in the field of medical translation. Read the press release |
|
|
In a study undertaken in more than 10,000 individuals, and published in Nature Communications, scientists have shown that integrating information derived from different technologies to measure proteins can identify otherwise hidden links between proteins and human health and disease. The international research team led by scientists from the BIH and from the Medical Research Council (MRC) Epidemiology Unit at the University of Cambridge provides a detailed view on how hundreds of plasma proteins are linked to hundreds of diseases and measures of health, showing that in several cases it might rather be the structure of a protein rather than its blood concentration that may mediate the effect. Read the press release and an interviewRead the publication |
|
|
In late November 2021, elections for the Section Management posts, the Extended Board of Directors and the Women’s Election Committee took place. The BIH has enshrined in its statute that a gender parity distribution of voting rights also applies to positions that are filled through institutional elections. This means that at the BIH, the composition of both the Section Management posts and the Extended Board of Directors will reflect gender parity. This ensures that women and men have an equal say in important decisions. By enshrining gender parity at the structural level, the BIH is setting an example that is being watched with considerable interest by other research institutions. Read more / To the elected |
|
|
Preparation BIH Faculty Retreat 2022
In December and January 2021, BIH scientists will jointly shape the strategic priorities for the years 2022–2027 in four workshops. The plans will subsequently be presented to the BIH Scientific Advisory Board at the next BIH Faculty Retreat on 24 and 25 February 2022 to get an external advice for further refinements. |
|
Until 24 December 2021, we are presenting special women on the BIH Twitter and BIH Instagram account who have shaped science beyond the city limits of Berlin or are still decisively advancing research. Our showcase journey started on 1 December. Take a look!
BIH Twitter
BIH Instagram
|
|
Dr. Kirsten Kübler, a faculty member at Harvard Medical School, has been awarded the Johanna Quandt Professorship for Early Cancer Development and Prevention at the BIH. She wants to use bioinformatic and experimental methods to better understand the early development of cancer in order to be able to intervene and prevent it in the long term. Kirsten Kübler is the recipient of one of four new Johanna Quandt Professorships, which Stiftung Charité established and funded this year at the BIH as part of its Johanna Quandt Private Excellence Initiative. This is the second time that Stiftung Charité and the BIH have held an international open-topic call for Johanna Quandt Professorships. Kirsten Kübler started her work at BIH on 1 November 2021. Read the press release |
|
|
Scientists at the BIH around René Hägerling and Charité have developed an automatable method for the histological examination of three-dimensional tissue preparations. Their idea could revolutionize microscopic tissue examinations and ease the burden on pathologists. The three founders of the project 3D-HistoPATH have now won a grant of over one million euros from the EXIST Transfer of Research aid program run by the German economics ministry. This will enable the scientists to develop their prototype into an end-to-end histopathology platform over the next two years. Read the press release |
|
|
DHA-funded Project Wins Health-i Trophy
We congratulate MyaLink, funded by the BIH Digital Health Accelerator (DHA), on winning the first prize of the Health-i-Award of the Handelsblatt and the Techniker Krankenkasse. The young team around Dr. Sophie Lehnerer and Dr. Maike Krause from Charité wants to connect patients with rare diseases and specialists via a digital platform. Read more (only in German)
|
|
News From the BIH Biomedical Innovation Academy (BIH)
|
|
|
News From the BIH QUEST Center
|
|
|
The BIH QUEST Center has developed a dashboard that provides an up-to-date overview of the status quo (as well as the progress) of various metrics of trustworthy and useful research at Charité and BIH. Examples of metrics shown are open sharing of data and analysis code in Charité publications and publication rates of clinical trials." Read more
|
|
News From Charité BIH Innovation (CBI)
|
|
|
As innovation drivers at Charité and BIH, the enabler programs SPARK-BIH and the BIH Digital Health Accelerator (DHA) from Charite BIH Innovation presented their programs during the state visit of Denmark's Queen Margrethe II and Crown Prince Frederik at Charité in November 2021 to the danish delegation and networked with some of the leading life science actors from the Nordic country. Read more |
|
|
On 26 November 2021, Professor Harry Hemingway, (Research Director HDR UK | Director UCL Institute of Health Informatics | Charité Guest Professor), spoke about the systematic interrogation of data for the benefit of healthcare systems across the world. In his lecture Hemingway presented opportunities and challenges in developing a prognostic atlas for clinical medicine. Read more
Video Presentation
Download Presentation |
|
|
On 3 December 2021, the third and last workshop of the Charité Flagshipprogram for the Berlin Leadership Academy took place within the framework of Berlin University Alliance (BUA). The BIH Biomedical Innovation Academy (BIA) has designed and implemented the new leadership program entitled "Effective and efficient decision making – lead confidently in challenging situations". Twelve professors from the BUA partners explored various aspects of decision-making from sole decision-making to participatory decision-making to personnel decision-making. In 2022, the Charité Flagship program will be offered again. Read more |
|
|
On 9 November 2021, a workshop on uploading the results of their clinical trials onto EudraCT, organized by the BIH QUEST Center was attended by more than 180 participants from more than 20 countries. The lectures of speakers Britta Lang (KKS-Netzwerk e.V.), Nick Devito (University of Oxford), Francesca Scotti (European Medicines Agency) and Birgit Whitman (University of Birmingham) were followed by a Q&A session that gave the participants the opportunity to directly talk to several experienced registry managers and the speakers. Further workshops are planned for early 2022. The topics will be based on a poll amongst the participants of the workshop. In addition, the creation of a European network for trial managers is in planning. Presentations and videos of the workshop Read more |
|
|
The I4H program was designed by SPARK-BIH and funded by the Stiftung Charité, to enhance the development of breakthrough medical innovations and help create a new generation of inventors. On the final I4H Pitch Day on 13 December 2021, the I4H teams presented how their ideas developed through the program and receive valuable feedback and network opportunities. Read more |
|
On 9 December 2021 SPARK-BIH, MDC and Bayer hosted the first joint Berlin Science Slam and strengthened the local collaboration with pitches and the exchange for young scientists. Read more
|
|
Due to the current situation regarding Sars-CoV-2/COVID-19 almost all BIH events will be implemented by using online tools, as noted in the event calender. If you would like to receive a regular overview of upcoming BIH Events, please register here. Many thanks. |
|
|
With the BIH Visiting Professors, Stiftung Charité supportes guest stays of several months of leading scientists from abroad or from other locations in Germany at Charité, the BIH and the MDC in order to give important impulses for the academic landscape and the innovation ecosystem in Berlin by sharing their experience, knowledge, and scientific and technological ideas. Stiftung Charité supports Visiting Professors with funds from its Private Excellence Initiative Johanna Quandt. The application deadline is 15 March 2022, 11:59 CET. Read more |
|
|
Anna Heyne
Since mid-November 2021, Anna Heyne has been supporting the team Management of Funds as a clerk. She studied Public and Nonprofit Management and gained experience in third-party funding management (EU office) during her studies. After her studies, Anna Heyne was employed at the Federal Employment Agency (Bundesagentur für Arbeit).
|
|
|
|
|
